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HIV in the elderly: An emergent challengeThe age distribution of human immunodeficiency virus
(HIV)-infected individuals is generally younger. However,
HIV prevalence and incidence among people aged 50 years
and older (elderly group) seem surprisingly high from the
scant data that exist.1e3 The prevalence data are limited
because elderly people are rarely included in demographic
health surveys in the developed, not to mention the devel-
oping, countries. There were only 13 of 30 surveys which
included older males, and none included older females, in
a World Health Organization (WHO) report.1 Nevertheless,
the incidence of HIV epidemics in elderly individuals appears
to be increasing. Although the developing countries have
limited case reporting systems, in the United States, the HIV-
positive cases through reporting system have climbed from
20% to 25% from 2003 to 2006 in the elderly group.1,4 Similar
case reporting data from the WHO’s European Region in
elderly individuals in 2005 shows 8%.5 By estimation, there is
a consistent pattern that prevalence in elderly individuals is
one-quarter to one-third that of the 15e49-year age group,
which is unexpectedly high.1
Although 50 years old is not the usual definition for the aged
group, the Centers for Disease Control and Prevention identi-
fied a group of HIV-infected patients aged 50 years and older
who presented with higher morbidity, higher mortality, and
a shorter acquired immunodeficiency syndrome (AIDS)-free
survival time than younger patients in the early days of the HIV
epidemics.2,3 Subsequent studies adopted this age threshold for
comparing young and elderly HIV-infected individuals. After
the introduction of highly active anti-retroviral therapy
(HAART), the median age at the development of AIDS has
been older, partly because of the effect of HAART in reducing
mortality and mobility of people infected with HIV and partly
because of the emergence of a late-diagnosed AIDS group,
HIV-infected people aged 50 years and older.3,6e8
The considerations for managing and treating elderly HIV-
infected individuals may be different from those in the
younger.3,8 With the advent of HAART, the life expectancy of
individuals with HIV infection has been dramatically prolonged.
Recently published data indicated that the average life expec-
tancy for a patient at the age of 20s is 43 years.8,9 However,
limited information was available for the elderly group.
Although prevention and early diagnosis plus treatment are two
cornerstones in combating HIV infection, prevention campaigns
generally target the younger. Furthermore, many elderly people1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.03.001do not consider themselves to be at risk.8,10 As a consequence,
older patients are likely to present with advanced HIV disease,
mainly because of inadequate risk assessment by doctors and
late diagnosis, and therefore have poorer outcome.8,10 Treat-
ment considerations for the elderly are different. It is well
accepted that the general immune status decreases with age, but
some studies showed similar response for the elderly group
compared with the younger. A multicohort collaboration study
indicated that elderly HIV-infected individuals are subject to
poorer immunological responses and increased clinical risk by
HAART; however, the efficacy of viral load reduction by these
medications may be better in the elderly group.11
Starting from the first autopsy-proven HIV/AIDS case in
Taiwan in 1985,12 information related to this disease in the
elderly population in Taiwan has been limited. Concerning the
rapid increase of aged people in the Taiwanese population, it is
imperative to understand the epidemiological status of HIV
and AIDS in the elderly. In this issue of the Journal of the
Chinese Medical Association, Kang et al.13 report the char-
acteristic epidemiological features of elderly HIV-infected
individuals in Taiwan. They retrospectively reviewed the
National HIV/AIDS Registry data, with emphasis on the
newly diagnosed cases in 2007. There were 153 in the elderly
group and 1,458 in the younger (age between 15 and 39). They
found similar patterns of acquisition of the disease in both
groups in terms of sex and nationality distribution, mode of
transmission, and ways of surveillance. However, there were
distinct features for the elderly group. The marital status and
occupational distribution were different. Furthermore, the
elderly group presented with fewer inmate cases, higher number
of heterosexuals, high mortality and higher ratio of initial
presentation as AIDS. The percentage of newly reported elderly
individuals with HIV in this report is similar to that from the
WHO’s European Region (7.7%, 153/1,975) but less than the
US survey. However, the number of injection drug users (IDUs)
was relatively high in this series, probably reflecting the HIV in
IDUs starting from 2003.14 It would be more informative if the
authors analyzed the HIV/AIDS data for a longer period of time
(several years) to demonstrate the chronological change of the
epidemics in Taiwan. It is surprising that the authors report
a high percentage of joblessness in both the younger and elderly
HIV-infected individuals, indicating a potential socio-economic
problem. Proper interventions and supports from in-charge
authorities may help.hinese Medical Association. All rights reserved.
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among elderly individuals and the implementation of nation-
wide distribution of free HAART since 1997,7,15 the pop-
ulation expansion of HIV-positive cases in elderly people is
expected. Although HAART resulted in dramatic decreases in
disease transmission, hospital administration and mortality
from HIV infection,7,15,16 new challenges emerged. The
elderly group with HIV infection is prone to side effects and
toxicities of HAART as well as age-related co-morbidities,
such as metabolic, cardiac, neurological, hepatic or renal
diseases. The impact of anti-retroviral therapy for the older
group merits further investigation.
In conclusion, the percentage of the elderly in HIV/AIDS-
infected individuals seems to be increasing. Considering the
limited information available for this group, it is imperative to
pay more attention in terms of disease prevention and early
detection of HIV infection. At the same time, combining close
surveillance of the HIV/AIDS epidemiological trend and
proper treatment protocols, we might be able to control and
improve the life quality in the long-term treatment of this
chronic viral disease in the elderly.
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